SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Greenwich LifeSciences, Inc. (GLSI) (CIK 0001799788) (GLSI) — Dec 15, 2020

Greenwich LifeSciences, Inc. (GLSI) (CIK 0001799788)
Date: Dec. 15, 2020 · CIK: 0001799788 · Accession: 0001493152-20-023672

AI Filing Summary & Sentiment

Date
Dec. 15, 2020
Author
Chief
Form
CORRESP
Company
Greenwich LifeSciences, Inc. (GLSI) (CIK 0001799788)

Letter

Greenwich LifeSciences, Inc.

Bluebonnet Dr, Building 14

Stafford, TX 77477

December 15, 2020

VIA EDGAR

United States Securities and Exchange Commission

F Street, N.E.

Washington, D.C. 20549

Attention: Jeffrey Gabor

Re: Greenwich LifeSciences, Inc. (CIK: 0001799788)

Registration Statement on Form S-1

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Greenwich LifeSciences, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Thursday, December 17, 2020, or as soon thereafter as possible.

Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

GREENWICH LIFESCIENCES, INC.

By: /s/ Snehal Patel

Name:

Snehal Patel

Title: Chief Executive Officer

Show Raw Text
CORRESP
1
filename1.htm

Greenwich
LifeSciences, Inc.

3992
Bluebonnet Dr, Building 14

Stafford,
TX 77477

    December
    15, 2020

VIA
EDGAR

United
States Securities and Exchange Commission

100
F Street, N.E.

Washington,
D.C. 20549

Attention:
Jeffrey Gabor

    Re:
    Greenwich
    LifeSciences, Inc. (CIK: 0001799788)

    Registration
    Statement on Form S-1

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Greenwich
LifeSciences, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred
to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Thursday, December 17, 2020,
or as soon thereafter as possible.

Please
notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible
as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

    GREENWICH
    LIFESCIENCES, INC.

    By:
    /s/
    Snehal Patel

    Name:

    Snehal
    Patel

    Title:
    Chief
    Executive Officer